These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6298277)

  • 1. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
    Macfarlane DE; Srivastava PC; Mills DC
    J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two distinct adenosine diphosphate receptors in human platelets.
    Colman RW; Figures WR; Colman RF; Morinelli TA; Niewiarowski S; Mills DC
    Trans Assoc Am Physicians; 1980; 93():305-16. PubMed ID: 6264660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a receptor for ADP on blood platelets by photoaffinity labelling.
    Cristalli G; Mills DC
    Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):875-81. PubMed ID: 8387782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
    Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW
    J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets.
    Macfarlane DE; Mills DC
    J Cyclic Nucleotide Res; 1981; 7(1):1-11. PubMed ID: 6265510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of adenosine diphosphate to human blood platelets and to isolated blood platelet membranes.
    Lips JP; Sixma JJ; Schiphorst ME
    Biochim Biophys Acta; 1980 Apr; 628(4):451-67. PubMed ID: 6245712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
    Savi P; Laplace MC; Maffrand JP; Herbert JM
    J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747.
    Sugidachi A; Asai F; Yoneda K; Iwamura R; Ogawa T; Otsuguro K; Koike H
    Br J Pharmacol; 2001 Jan; 132(1):47-54. PubMed ID: 11156560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor.
    Egan CM; Fisher AP; Scrutton MC
    Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-steady state study of beta-adrenergic and purinergic receptor interaction in C6 cell membranes: undelayed balance between positive and negative coupling to adenylyl cyclase.
    Valeins H; Merle M; Labouesse J
    Mol Pharmacol; 1992 Dec; 42(6):1033-41. PubMed ID: 1336111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
    Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
    Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1989 Aug; 984(1):113-8. PubMed ID: 2548620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
    Hall DA; Hourani SM
    Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1981 Jun; 73(2):405-8. PubMed ID: 7236992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
    Hall DA; Hourani SM
    Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.